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For high-throughput structural studies of protein
complexes of composition inferred from proteomics
data, it is crucial that candidate complexes are
selected accurately. Herein, we exemplify a proce-
dure that combines a bioinformatics tool for complex
selection with in vivo validation, to deliver structural
results in a medium-throughout manner. We have
selected a set of 20 yeast complexes, which were
predicted to be feasible by either an automated
bioinformatics algorithm, by manual inspection of
primary data, or by literature searches. These com-
plexes were validated with two straightforward
and efficient biochemical assays, and heterologous
expression technologies of complex components
were then used to produce the complexes to assess
their feasibility experimentally. Approximately one-
half of the selected complexes were useful for struc-
tural studies, and we detail one particular success
story. Our results underscore the importance of
accurate target selection and validation in avoiding
transient, unstable, or simply nonexistent complexes
from the outset.
INTRODUCTION
Numerous large-scale proteomics initiatives in the model
organism Saccharomyces cerevisiae have been reported overStructure 18, 1075–10the last few years and have provided evidence for thousands
of new protein interactions and supplied a wealth of information
about the composition of macromolecular complexes (Gavin
et al., 2006; Ho et al., 2002; Ito et al., 2001; Krogan et al.,
2006; Tarassov et al., 2008; Uetz et al., 2000). Nevertheless,
the characteristics of protein interaction networks in vivo have
not yet been rigorously untangled for any organism, let alone
the faithful budding yeast. Now that such protein interaction
data sets are in the public domain, a gauntlet has been thrown
down to the scientific community to provide tools for assimilating
these data with a view to developing algorithms and experi-
mental methodologies for predicting the composition of com-
plexes with high accuracy, thereby facilitating their functional
and structural characterization.
However, for many predicted complexes identified in high-
throughput affinity purification experiments, their subunit com-
position is not established with sufficient reliability to proceed
to structure determination. Improvements in the confidence
that can be placed in protein interaction models are therefore
clearly needed, with the specific aim of identifying complexes
with well-defined stoichiometry, and which are amenable to
structural studies. Raising the confidence with which complex
composition could be predicted would benefit enormously the
field of structural biology. Ideally, it would be possible to identify
stable complexes (for example, ribosomes, RNA polymerases,
the exosome, or the 20S proteosome) and discriminate them
frommore dynamic assemblies that contain transient interactors
(for example, spliceosomes or the 26S proteosome). It would
therefore be beneficial to classify and characterize the various
entities which form the central frameworks of protein-protein
interaction networks (Gavin et al., 2006; Higurashi et al., 2008;
Krogan et al., 2006).82, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1075
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Protein Complex Validation for Structural BiologyForemost among the problems encountered in complex
characterization are those related to the primary data being of
limited quality. For example, the heterogeneity or the extremely
dilute nature of samples from proteomic experiments results in
complex subunits being overlooked. Additionally, in some
studies, the characterization of complex composition has been
hindered by the contamination of bona fide complexes by so-
called ‘‘background’’ or ‘‘sticky’’ polypeptides that interact with
other proteins in a promiscuous fashion (Shevchenko et al.,
2002). One challenge is therefore to devise a computational
strategy to filter through the results of many thousands of
biochemical purifications which have been performed to date,
and identify the complexes that will yield the optimal results
duringexpressionandpurificationstudies (BravoandAloy, 2006).
The first structural genomics consortia focused on the deter-
mination of X-ray and NMR structures at the level of the single
protein (Alzari et al., 2006; Graslund et al., 2008; Marsden
and Orengo, 2008). More recently, the Structural Genomics
Consortium (SGC) (Edwards et al., 2002), the 3D Repertoire
(http://www.3drepertoire.org/) and SPINE 2 - Complexes (http://
www.spine2.eu/) consortia have opted to study macromolecular
complexes from amedium-throughput perspective. The expres-
sion and purification of protein complexes adds an extra level of
complexity, since globular protein interfaces are often partly
hydrophobic, and single partners may be insoluble. In many
cases, only in the context of an assembled complex do hydro-
phobic interfaces become buried and the participating polypep-
tides can be produced as soluble entities (Dyson and Wright,
2005; Smialowski et al., 2007).
Since the inception of the European Commission-funded
consortium ‘‘3D repertoire’’ in 2004, collaborating scientists
have been addressing the problems associated with identifying
complexes de novo for structural studies. Within the first step,
which consisted of highly selective filtering of existing data
sets for evidence of the existence of complexes in a process
we term ‘‘complex triage,’’ three methods were employed. First,
a bioinformatics-based selection procedure, optimized using a
training set composed of complexes of known three-dimen-
sional (3D) structure, was used to screen for stable, well-folded
complexes. Second, we examined the results from high
throughput affinity purification experiments manually, focusing
on the visual inspection of gels to identify complexes of which
the components existed in stoichiometric quantities. Finally, a
set of seven complexes was chosen on the basis of the scientific
literature.
A compilation of these complexes, named the ‘‘list of 20,’’
were then validated by new affinity purifications of the natural
complexes and their subunit compositions were confirmed using
mass spectrometry. In addition, the solution sizes of these
complexes were assessed by size exclusion chromatography.
The subset of proteins that were shown to indeed participate
in macromolecular assemblies as predicted and that were also
believed to be tractable for structural studies was then cloned
and expressed in Escherichia coli. Using various techniques,
we aimed to obtain purified material suitable for structural
analysis. We show the overall success in each of the steps of
this procedure and present a detailed account of one example
complex. The results from this test set of complexes under inves-
tigation have allowed us to evaluate the effectiveness of each of1076 Structure 18, 1075–1082, September 8, 2010 ª2010 Elsevier Ltthe techniques used and devise an optimal route for the produc-
tion of protein complexes in structural biology pipelines.
RESULTS
Identification of Complexes for Structural Studies
Complex Triage by Bioinformatics
A system based on the notion that complexes likely amenable to
structural studies should be small, compact, and homogeneous
has been previously described (Gavin et al., 2006). We consid-
ered biophysical, biochemical, and large-scale proteomics
data in the form of partial scoring functions that were normalized
and combined into a final feasibility score for each complex.
The algorithms that define our scoring function, hereafter called
the Complex Feasibility (CF) algorithm, have been published
elsewhere (Pache and Aloy, 2008); details are available
in http://gatealoy.pcb.ub.es/targetselection/help.html and the
main issues are summarized in Supplemental Experimental
Procedures (available online).
For the evaluation set of complexes we use in this study
(Table 1; Table S3), we combined four of the top-ranking com-
plexes made by the CF tool (which we expected to behave
very well for structural studies), with three mid-ranking com-
plexes (which we expected to present more of a challenge for
structural studies).
Complex Triage by Manual Visualization of Gels
Complexes with apparently stoichiometric components are
more likely to indicate stable interactions and be more suitable
for structural studies. In the original genome-wide approach
(Gavin et al., 2006), tandem affinity-purified (TAP) assemblies
were separated by denaturing gel electrophoresis and stained.
The gels were then cut into 1 mm slices, digested with trypsin,
and analyzed by MALDI-TOF mass spectrometry (MS). This
procedure did not take into account the relative quantities of
proteins present in the TAP eluate.
We thus decided to visually inspect the original gels (Gavin
et al., 2006) for bands indicative of stoichiometric complexes.
Thorough inspection of about 4000 purification experiments
identified64promising complexes (TableS4: dimeric complexes;
Table S5: trimeric complexes; Table S6: tetrameric complexes).
Some of the 64 chosen complexes have not been identified as
being complexes in the original automated annotation (Gavin
et al., 2006) andwere thus not considered in the CF classification
algorithm. Notably, the best six complexes that were chosen
independently by gel inspection were all in the top 50 of the CF
algorithm, and two of them were in the top 10. Six complexes
were finally selected by manual gel inspection (Table 1).
The List of ‘‘20 Complexes’’
We finally selected 20 complexes; the corresponding bio-
informatics and gel scores, and when possible appropriate
references to the literature are summarized in Table 1.
Although the manual gel inspection and the bioinformatics
efforts were independent, all previously identified complexes
selected by manual screening had a high ranking using the
CF algorithm. In contrast, not all of the complexes chosen by
the algorithm could be associated with clear and conclusive
gels. Notably, a top-ranked choice was associated with a gel
of mediocre quality. Nonetheless, such types of selections re-
sulted in a potentially interesting collection of complexes thatd All rights reserved
Table 1. Summary of Target Selection, Validation, and Complex Reconstitution Results
Selection Validation Single subunit expression Complex production Stage      
  Complex Gel Quality Rank TAP Results 
Subunit 
 1 
Subunit  
2 
Reconstit
ution
a
 
Separate 
plasmid co-
expression  
Operon co-
expression 
Bioinformatics Analysis 
Ste11, Ste50 Good 1 Heterogeneous + - - ND ND 
Atg17, Atg20, Atg29 Good 27 Partial (-Atg29) + - ND - - 
Vps27, Hse1 Excellent 1 Excellent + + + + ND 
Psy2, Psy4, Pph3 Excellent 4 Partial (-Pph3) + - ND - ND 
Nup82, Nup159, Nsp1 Good 4 Excellent ND ND ND ND ND 
Ede1,Syp1 Good 22 Excellent ND ND ND ND ND 
Dop1, Mon2 Excellent 25 Aggregated ND ND ND ND ND 
Gel Analysis 
Gcd14, Gcd10 Excellent 12 Excellent + + + + + 
Ptc2, Paa1 Excellent 8 Paa1  promiscuous + + + ND ND 
Met12, Met13 Excellent 22 Excellent + + ND + ND 
Dug3, Dug2 Excellent 9 Excellent + + ND + ND 
Ssl2, Yor352w Excellent 27 Excellent + + ND + + 
Spt6, Spn1 Excellent 40 Partial (-Spn1)  ND ND ND ND ND 
Literature Analysis 
Rad17, Mec3, Dcd1 Failed 261 Failed ND ND ND ND ND 
Orc1-6 Good 29 Heterogeneous ND ND ND ND ND 
Rbg2, Gir2 Good 5 Excellent + + ND + + 
No Interaction 364 No Interaction + + + ND ND 
Rps28B, Edc3 No Interaction 364 Edc3 promiscuous ND ND ND + + 
Sis2, Ykl088w, Vhs3 Partial Interaction 323 Weak expression ND ND ND ND ND 
Mtw1,Dsn1,Nnf1,Nsl1 Partial Interaction 11 Weak expression ND ND ND ND ND 
Dom34, Hbs1b
Complexes selected by bioinformatics, gel, and literature analyses, respectively, are listed. The complexes were assessed according to their purity
after TAP purification (column labeled ‘‘Gel quality’’). The ranks according to the CF algorithm of each of the complexes (‘‘Rank’’), as well as the results
of validation by tandem affinity purification (cf. Figure S1; ‘‘TAP Validation’’ and Figure S2 for the results of complex production and Table S4) are
shown. Results of expression, coexpression, and reconstitution studies are as follows: +; successful, -; unsuccessful, ND; not determined, NA; not
applicable. See also Tables S1, S2, and S3.
a The Gcd10:Gcd14 complex was not reconstituted from purified proteins, but instead cells in which the proteins had been expressed separately were
combined prior to sonication. For clarity, results that were deemed to be ‘‘positive’’ (having a ‘‘good’’ gel quality, high ranking in the bioinformatics
triage, significant expression levels or production of the relevant complex by either coexpression or by reconstitution) are shown with a green
background. Similarly, ‘‘mediocre’’ results in the TAP validation (indicating that either heterogenous or partial complexes were purified) are shown
with a yellow background. Negative results, indicating either a poor gel quality, low bioinformatics rank, failed TAP validation experiment, failed expres-
sion, or failed complex production, are shown in red. Expression results for the complexes not deemed to be suitable for structural analysis are shown
as gray text.
b Reconstitution of the Dom34:Hbs1 complex had been described previously (Graille et al., 2008).
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Protein Complex Validation for Structural Biologywould hopefully be amenable to structural studies. The selec-
tion was complemented by the choice of an additional seven
complexes suggested by partners of 3D repertoire, based on
specific biological interests and literature know-how, reaching
the final number of 20 complexes included in this study. Inter-
estingly, only one of the latter choices was in the top 10 bio-
informatics list, and an additional two were in the top 50; the
remaining four scored poorly in the CF algorithm.
Validation of Complex Composition
The 20 selected complexes were validated in a two-step TAP
purification on IgG and calmodulin columns. Mass spectrometryStructure 18, 1075–10analyses using an ESI-TRAP approach were performed using
both the eluate solutions and the excised gel bands as samples.
In addition, molecular weights of complexes were estimated by
size exclusion chromatography of total extracts, followed by dot-
blot detection of TAP-tagged proteins in eluate fractions. Finally,
the molecular weights of tagged subunits and the efficiency of
binding to IgG resin were verified by western blot analyses (see
Figure 1 for a schematic representation of the procedure). The
conclusions regarding individual complexes are presented in
Table 1 and Figure S1.
Only two of the complexes completely failed this validation
stage, one for technical reasons and one could not be identified82, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1077
Figure 1. Strategy for the Validation of
Selected Complexes
A schema showing the overall pathway for the
validation of complex composition and estimation
of molecular weight of each complex is presented.
The complexes were expressed in yeast using a
C-terminal TAP-tag of the bait protein. Following
cell breakage, complexes were either subjected
to TAP purification to assess the subunit composi-
tion, or to gel filtration in order to estimate the
molecular weight, and thereby their stoichiometry.
See Figure S1 for actual results of the validation
experiments.
Structure
Protein Complex Validation for Structural Biologyat all. Interestingly, both complexes originated from the literature
additions to the list and they both scored poorly in the bioinfor-
matics assessment. This category, where literature knowledge
was used to select complexes, gave a lower validation rate
than the other strategies. Apart from the one complex for which
no technically valid results were obtained, one failed, while two
others showed too weak native expression to be conclusive.
Another complex was highly heterogeneous and one included
a very promiscuous protein as a partner and was thus inconclu-
sive. Notably, one complex selected from the literature and
validated here to be ‘‘excellent’’ was ranked in the top 10 (20th
percentile) of the bioinformatics list. The low validation rates
of complexes selected from the literature, and their low bio-
computing ranks stem from their specific characteristics (low
abundance, specific interaction involving abundant partners
flagged as promiscuous) and underline the limitation of current
strategies to identify bona fide complexes. The gel-selected
complexes and the bioinformatics complexes fared well in the
validation, with four out of six and three out of seven, respec-1078 Structure 18, 1075–1082, September 8, 2010 ª2010 Elsevier Ltd All rights reservedtively, being scored as ‘‘excellent.’’
From the validated complexes, 11 were
chosen for heterologous expression
studies and production in quantities
suitable for structural studies. Analysis
of the twelfth complex, Dom34:Hbs1 is
described elsewhere, so was not re-
peated (Graille et al., 2008) but is included
in Table 1.
Recombinant Production
ofComplexes for Structural Studies
For these 11 complexes, a mixture of
expression strategies was employed for
their evaluation: expression of the full-
length individual subunits, in vitro com-
plex reconstitution from subunits, and
coexpression. A total of 22 proteins
have been used in expression trials as
single full-length proteins in E. coli, either
from synthetic, codon-optimized genes
(16 proteins, Figure 2A) or from natural
yeast genes (Figures S2–S6). Only three
of these failed to produce soluble pro-
tein in appreciable amounts (Atg29,Psy4, and Ste11). We proceeded to reconstitute four complexes
(Vps27:Hse1, Ptc2:Paa1, Ste11:Ste50, and Gcd10:Gcd14) from
individually purified partners and succeeded in purifying three in
soluble form and defined subunit composition (Figures S3–S6).
In parallel, we also attempted coexpression of nine complexes:
in these experiments only one of the two subunits was N-termi-
nally tagged with a 6-His tag. In seven out of nine cases, we were
able to produce both proteins and purify them as a complex by
metal affinity chromatography (Figure 2B).
A Case Study of an Example Complex, from Selection
to Validation
To illustrate the course of an experiment from target selection to
validation, we present one particular exemplary complex. The
Gcd10:Gcd14 complex was originally identified a few years
ago and purified as a dimeric tRNA(1-methyladenosine) methyl-
transferase (Anderson et al., 1998, 2000; Ozanick et al., 2007).
Gavin et al. (2006) observed again this dimeric complex, which
was annotated as Complex 376 in the Krogan et al. (2006)
Figure 2. Expression and Purification of Yeast Full-Length Proteins
(A) SDS-PAGE analysis of full-length yeast constructs produced using codon-
optimized synthetic genes, Ni2+-NTA-purified and visualized using Coomas-
sie. Full-length proteins were expressed and purified as above and eluted
material was analyzed by SDS-PAGE. The samples are relatively pure after
only one step of purification, although degradation products are sometimes
present. Molecular weight markers and their sizes are indicated on both sides
of the gel. Successful constructs are Atg17 (48.7 kDa), Dug2 (98.1 kDa), Dug3
(40.2 kDa), Gcd10 (54.4 kDa), Gcd14 (43.9 kDa), Met12 (73.9 kDa), Met13
(68.6 kDa), Psy2 (98.1 kDa), Rbg2 (41 kDa), Gir2 (31 kDa), Ssl2 (95.3 kDa),
Yor352w (39.3 kDa), Vps27 (71.9 kDa), Hse1 (51.1 kDa), while the unsuccessful
constructs are Atg20 (72.5 kDa) and Psy4 (50.7 kDa).
(B) The nine complexes successfully produced in a recombinant form.
Ni2+-NTA-purified samples of the results of complex formation trials were
subjected to SDS-PAGE analysis and visualized using Coomassie. For coex-
pressed complexes the tagged component is marked with an asterisk below,
while reconstituted complexes are not marked: Gcd10:Gcd14 (54.4 and
43.9 kDa, respectively), Paa1:Ptc2 (21.9 and 50.3 kDa), *Met12:Met13
(73.9 and 68.6 kDa), Dug2:*Dug3 (98 and 40.2 kDa), Ssl2:*Yor352w (95.2
and 40.2 kDa), Hbs1:Dom34 (68.7 and 44.1 kDa), Vps27:Hse1 (71.9 and
51.1 kDa), *Gir2:Rbg2 (31 and 41 kDa), Dug2:Dug3* (98.1 and 40.2 kDa),
*Rps28B:Edc3 (7.6 and 61.3 kDa) complexes. Bands corresponding to the
proteins of interest are arrowed.
See also Figures S2, S3, S4, S5, S6, and S7.
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Protein Complex Validation for Structural Biologyenumeration. TAP-purified Gcd10:Gcd14 has also been shown
to be relatively homogeneous and therefore pure by electron
microscopy. We selected this complex by gel analysis but it
also ranked with a score of 12 by the CF algorithm.
First, we revalidated the complex by repeating the TAP purifi-
cation using tagged Gcd14 and the only partner that was
isolated wasGcd10, with no other bands either apparent or iden-
tified by mass spectrometry Figures 3A and 3B). Gel filtration
analysis of the TAP-tag-purified complex was consistent with
a molecular weight of approximately 350 kDa, suggesting the
formation of higher order multimers since the expected mass
of the Gcd10:Gcd14 complex with a 1:1 stoichiometry is
98.3 kDa.
The complex was reconstituted from the Ni2+-NTA-purified
individual components and subjected to gel filtration chromatog-
raphy. The resulting complex had an approximate molecular
weight of around 350 kDa, in agreement with the analysis of
the ‘‘native’’ TAP-tagged complex (Figure 3B). The purified
complex was then used in a negative stain electron microscopyStructure 18, 1075–10experiment. The sample was homogeneous and could be used
for data collection (Figure 3C). Image reconstructions without
any imposed symmetry showed a tetrameric core with exten-
sions at opposite surfaces, giving the entire complex 2-fold, as
well as quasi 4-fold symmetry. Therefore, C2 symmetry was
imposed for further refinement. The final reconstruction is shown
in Figure 3E. Projections of this reconstruction agree with class
averages were determined by multivariate statistical analysis
(Figure 3D).
DISCUSSION
In this work, we set out to identify an optimal strategy for the
analysis of Saccharomyces cerevisiae complexes by combining
contemporary structural biology tools with the numerous pro-
teome-level biochemical interaction data sets. Our central tenet
was that we believed such data to be essentially reliable, and that
the use of improved bioinformatics tools, manual analysis of gels
or bibliographic curation of previous data should allow the iden-
tification of complexes best suited to structural analysis.
A question that we sought to answer related to whether
bioinformatics, and specifically the CF algorithm, could provide
trustworthy guidance when selecting targets. Ideally, the algo-
rithm should eliminate the need for manual inspection of data.
Therefore, we first generated a target list, partly using automated
tools and partly manually. The next step was to ascertain
which of the selected complexes do indeed exist in a stable
and stoichiometric form. Our experimental results show that
the bioinformatics algorithm could select targetswith a validation
success rate that was very high, and comparable to visual
inspection of gels.
In the final CF algorithm, the most important parameters were
the yeast two-hybrid ratio and the socio-affinity index (Table S2).
The usefulness of the former parameter has been obvious for
some time, since yeast two-hybrid screening has been a main-
stay of research into protein-protein interactions. However, the
important role of the socio-affinity index in this experiment was
encouraging (Gavin et al., 2006), and we believe that it is a valu-
able and powerful metric for the identification of protein
complexes based on protein interaction data sets. Conversely,
the least useful parameters were the ‘‘average number of
problematic residues’’ and the ‘‘colocalization ratio’’; it appears
that these parameters are not as useful as had been previously
thought, at least in the context of this work (Pache and Aloy,
2008).
We note that some complexes identified by bibliographic
analyses, which could not be validated and for which low scores
were obtained with the CF algorithm, performed well using
recombinant expression. These facts underline the limitation of
complex analyses of low abundance complexes and/or com-
plexes involving very abundant subunits for which it is difficult
to exclude the existence of promiscuous interactions. It is
possible that our complex triage procedures have been
successful at least in part, due to the clarity of primary data for
which the subunits are stoichiometrically equivalent and well
expressed.
The success rate of obtaining soluble subunits by heterolo-
gous recombinant expression, for the full-length proteins was
high (only 3 of 22 proteins tested could not be produced in82, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1079
Figure 3. Validation and Scale-Up of an
Exemplary Complex; Gcd10:Gcd14
(A) Both Gcd10 and Gcd14 were clearly visible
after purification using the TAP protocol, with little
evidence of contaminating proteins, validating this
complex.
(B) In order to estimate the size of the complexes,
yeast extracts were separated with the use of size
exclusion chromatography on a Superdex 200
column in low (150 mM; marked as ‘‘LO’’) and
high (500 mM; ‘‘HI’’) concentration of NaCl. Thirty
fractions from this chromatography step were
collected and spotted on a nitrocellulose
membrane. To detect fractions containing the
TAP-tagged protein, western blotting using PAP
antibodies was performed. See the legend to
Figure S1 for further details for (A) and (B).
(C) Micrograph of the Gcd10:Gcd14 complex
which had been purified as in Figure 2B and fixed
with glutaraldehyde, according to the GraFix
protocols (Ka¨stner et al., 2008) and stained with
uranyl-acetate in a sandwich between two layers
of carbon. Scale bar, 50 nm.
(D) Class averages of the data (top row) deter-
mined by multistatistical analysis agree with
projections of the 3D map (central row). Surface
presentations (bottom row) of the 3D map are
shown in the same directions as the projections
above. Scale bar, 5 nm.
(E) Image reconstruction of the Gcd10/Gcd14
complex. C2 symmetry was imposed during the
final rounds of refinement. The complex is shown
along the symmetry axis (left) and perpendicular
to the symmetry axis (right). Scale bar, 5 nm.
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Protein Complex Validation for Structural Biologya soluble form; 86% success rate). Similarly, we were able to
obtain soluble complexes corresponding to most of our vali-
dated targets using either complex reassembly or coexpression
via either cotransformation of plasmids or single plasmids
that contain operons encoding all of the proteins of interest
(cf. Table 1; Supplemental Experimental Procedures) (9 of 11
complexes could be formed; 82% success rate). We believe
that this achievement is principally due to the efficient selection
criteria that we had established. It has been reported that only
about 20% of full-length eukaryotic proteins are soluble when
produced in a heterologous expression system (Graslund
et al., 2008), but the performance of our approach is consider-
ably superior. This is likely to be because only natively soluble
proteins and complexes that are expressed at suitably high
levels are detected by mass spectrometry after TAP purification,
thereby biasing complex identification data toward soluble
proteins.
Based on the 4 year experience of a consortium of numerous
structural biology groups involved in 3D repertoire, we suggest
an optimal experimental strategy for the high-throughput study
of protein complexes. We conclude that, despite the absence
of a ‘‘silver bullet,’’ much can be achieved first by triaging the
targets by an efficient computational procedure, followed by
simple expression and reconstitution in the first instance. For
this, a LIC-based strategy to clone optimized synthetic genes1080 Structure 18, 1075–1082, September 8, 2010 ª2010 Elsevier Ltin a parallel manner resulted in notable success, with 14 of 16
subunits expressed in soluble form. During complex reconstitu-
tion, we had greater success when employing cosonication of
E. coli in which each subunit had been expressed separately,
compared with reconstitution using pure proteins and this has
become our method of choice to obtain soluble complexes
(cf. Supplemental Experimental Procedures: ‘‘Complex forma-
tion trials’’).
We also found that producing plasmids that encode the
necessary subunits as synthetic DNA, with Shine-Dalgarno
sequences upstream of the successive ORFs to be a very
practical and rapid method of coexpressing complexes (cf.
Supplemental Experimental Procedures: ‘‘Cloning strategy
used for poly-cistronic expression’’). Our studies into the use
of polycistronic vectors, particularly those constructed from
synthetic genes (e.g., Gcd10:Gcd14 and Ssl2:Yor352 com-
plexes) (Figure S7) indicate that this is a strategy that this is
a useful addition to pipelines, both because of the ease of
production of plasmid constructs, and the increase in yield
presented by codon-optimized genes.
In summary, we conclude that when initiating projects
involving high-throughput study of protein complexes proper
triaging and validation is obligatory. Despite clear advances in
bioinformatics procedures, the direct inspection of the experi-
mental primary data indicating the presence of a robust complexd All rights reserved
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Protein Complex Validation for Structural Biologyby the stoichiometric interaction of its constituent components,
as in our gel analysis of TAP-tagged complexes, remains the
most effective method of complex selection. Once triaging and
validation had been performed, it was relatively straightforward
to test the association of the recombinant proteins experimen-
tally. As we illustrate with the Gcd10:Gcd14 complex, we were
able to obtain structural information during the relatively short
timescale of this project. In this work, we have leveraged
complementary strategies to the end of complex production
for structural analysis, but we envisage the incorporation of
further techniques in subsequent experiments. For example,
high throughput small angle X-ray scattering studies of single
proteins could be applied similarly to complexes (Hura et al.,
2009), and it will be increasingly important to identify complex
and subcomplex composition of samples purified directly from
cells using native mass spectrometry (Hernandez et al., 2006).
Accurate subunit prediction and validation methods will be
beneficial to future high-throughput approaches geared toward
‘‘high-hanging fruit’’ and increase the probability that such
efforts will yield illuminating insights into macromolecular
machines at work.EXPERIMENTAL PROCEDURES
Validation
TAP Purification
TAP-tagged strains of Saccharomyces cerevisiaewere grown in 4 liters of YPD
medium (1% yeast extract, 1% bacto-peptone, 2% glucose) to an optical
density (O.D.) of approximately 2. Yeast pellets were resuspended in 40 ml
of lysis buffer (1 mM DTT, 40 mM HEPES [pH 8], 250 mM NaCl) and frozen
in liquid nitrogen. Cells were broken in a laboratory blender cooled with dry
ice. Extracts were defrosted with protease inhibitors and spun in 35Ti rotor
(Beckman) in a Beckman ultracentrifuge at 20,000 rpm for 20 min at 4C.
Supernatant was spun again at 32,000 rpm for 90 min at 4C. Resulting
extracts were dialyzed in buffer D (1 mM DTT, 40 mM HEPES [pH 8],
150 mM NaCl, 1 mM PMSF) and frozen in liquid nitrogen. Extracts were then
defrosted and incubated with 200 ml of IgG Sepharose 6 Fast Flow resin
(GE Healthcare) in the presence of 0.1% rTX-100 for 1.5 hr at 4C. The beads
were washed twice with 10ml IPP150 (10mM Tris-HCl [pH 8.0], 150mMNaCl,
0.1% rTX100) and twice with 10 ml TEV cleavage buffer (10 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 0.5 mM EDTA, 1 mM DTT). TEV cleavage was
performed for 2 hr using 20 mg of TEV protease in 300 ml of cleavage buffer
at room temperature. Eluates were agitated with 300 ml of calmodulin beads
suspension (Stratagene) for 0.5 hr at 4C. The beads were washed four times
with 500 ml of calmodulin wash buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl,
10mM b-mercaptoethanol, 1mMCaCl2) and the protein was elutedwith 0.6ml
calmodulin elution buffer (10 mM Tris-HCl [pH 8.0], 500 mM NaCl, 10 mM
b-mercaptoethanol, 0.1% rTX100, 4 mM EDTA). As a control, denatured
elution fractions from both IgG and calmodulin beads were prepared with
250 ml of 1% SDS at 60C.
Protein Precipitation and Analysis by Mass Spectrometry
Proteins were precipitated using pyrogallol red (Aguilar et al., 1999). When
salinity of buffer was higher then 200 mM of NaCl, the samples were first
adjusted to this concentration by dilution. Proteins were separated by electro-
phoresis performed on NuPAGE 4%–12% gradient gels using MES buffer gel
system (Invitrogen) and stained with SimplyBlue SafeStain (Invitrogen). Mass
spectrometry was performed both with IgG eluates in solution and from bands
cut from gels. Samples were then processed by standard procedures with
trypsin digestion and cysteine alkylation. The obtained peptide mixtures
were separated on a nano-HPLC system and the column outlet was coupled
to the ion source of an LTQ FTICR spectrometer.
Western Blot Analyses
After dialysis, extracts and flow-throughs after IgG Sepharose chromatog-
raphy were separated by 10% SDS-PAGE and electro-blotted onto theStructure 18, 1075–10Protran nitrocellulose membrane (Bioscience) using a Trans-Blot system
(Bio-Rad). The filters were blocked for 1 hr in 5%milk powder in PBS contain-
ing 0.1% Tween 20 and then the mouse monoclonal anti-rabbit immunoglob-
ulin-peroxidase conjugate (Sigma) diluted 3000-fold was added. After 1 hr, the
blots were washed three times in PBS with 0.1% Tween 20. Finally, horse-
radish peroxidase conjugates were visualized by enhanced chemilumines-
cence system (ECL, GE Healthcare).
Mass Determination of the Complexes
In order to estimate the size of the purified complex, the extract from
TAP-tagged strains was separated according to size, by size exclusion
chromatography on a Superdex 200 10/300 column (GE Healthcare) using
an Akta Purifier FPLC. Two different salt concentrations (150 and 500 mM
NaCl) were used for elution and fractions were collected into a 96 well plate.
Sixty microliters of every fraction was spotted on a nitrocellulose membrane.
TAP-tagged subunits were detected by Dot-Blot as described for western
blot analyses. The intensities of the spots were calculated with ImageQuant
(GE Healthcare) and exported into chromatograms. The column was cali-
brated using protein markers; thyroglobulin (670 kDa), ferritin (440 kDa), cata-
lase (232 kDa), aldolase (154 kDa), albumin (67 kDa), ovalbumin (43 kDa), and
chymotrypsin (25 kDa).
Electron Microscopy and Image Processing
The purified, overexpressed Gcd10/Gcd14 complex was fixed on a glycerol
gradient with glutaraldehyde according to the GraFix protocol (Ka¨stner
et al., 2008). Fractions of the gradient were further analyzed by dot-blot anal-
ysis using an antibody against the 6-histidine tag. The dot blot identified
a single peak with a maximum at fraction 14. Samples from the peak fractions
were prepared for subsequent electron microscopy by sandwich negative
stain using uranyl acetate as previously described (Ulbrich et al., 2009).
Samples were imaged at room temperature in a Philips CM120 Biotwin elec-
tron microscope at 100 kV. Data was recorded on a 4kx4k Tietz-CCD camera
at a nominal pixel size of 4.27 A˚ per pixel under low-dose conditions. For
further processing 10819 particle images were selected from 29 micrographs.
Three-dimensional models were calculated using sinogram correlation and
weighted back projection with IMAGIC 5 (van Heel et al., 1996). The process
of determining initial orientations followed by calculation of a three-
dimensional map was repeated several times using different class averages
for starting the sinogram correlation.
Projections of the resulting three-dimensional models were compared
with the initial class averages. The model that generated projections that
matched 90% of the initial class averages was selected for further refinement
by an iterative process of projection matching followed by calculating a new
3D map with Spider (Frank et al., 1996). After five rounds of refinement the
map was stable and showed an approximately 4-fold symmetric core with
extensions at opposite sides, giving thewholemap a 2-fold symmetric appear-
ance. Therefore, the map was refined for another five rounds imposing C2-
symmetry. The final map is calculated from the best correlating 5503 particles.
The resolution of the final map was determined by Fourier-Shell-Correlation
and was 23 A˚ (correlation = 0.5) (Figure S8).
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